| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplastic Stem Cells | 7 | 2025 | 348 | 1.580 |
Why?
|
| Glioblastoma | 5 | 2023 | 374 | 1.360 |
Why?
|
| Neoplasms | 7 | 2023 | 2946 | 1.000 |
Why?
|
| Pyrans | 2 | 2021 | 10 | 0.790 |
Why?
|
| Antineoplastic Agents | 3 | 2021 | 1829 | 0.720 |
Why?
|
| Phosphoproteins | 2 | 2025 | 443 | 0.710 |
Why?
|
| Pancreatic Neoplasms | 7 | 2020 | 728 | 0.650 |
Why?
|
| Endothelial Cells | 1 | 2023 | 530 | 0.630 |
Why?
|
| Tumor Microenvironment | 3 | 2025 | 688 | 0.610 |
Why?
|
| RNA-Binding Proteins | 2 | 2025 | 605 | 0.610 |
Why?
|
| Molecular Targeted Therapy | 2 | 2021 | 402 | 0.590 |
Why?
|
| Genes, Neoplasm | 1 | 2018 | 88 | 0.570 |
Why?
|
| Cell Line, Tumor | 17 | 2025 | 3698 | 0.560 |
Why?
|
| Antineoplastic Agents, Phytogenic | 4 | 2018 | 104 | 0.480 |
Why?
|
| Brain Neoplasms | 3 | 2020 | 1409 | 0.450 |
Why?
|
| Neoplastic Cells, Circulating | 2 | 2025 | 76 | 0.440 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2025 | 2064 | 0.440 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 701 | 0.430 |
Why?
|
| Cell Proliferation | 10 | 2025 | 2512 | 0.420 |
Why?
|
| Neuroblastoma | 1 | 2019 | 550 | 0.410 |
Why?
|
| Biomarkers | 1 | 2023 | 3391 | 0.410 |
Why?
|
| Triterpenes | 2 | 2018 | 24 | 0.400 |
Why?
|
| Hedgehog Proteins | 3 | 2020 | 263 | 0.400 |
Why?
|
| Lung Neoplasms | 4 | 2025 | 1541 | 0.390 |
Why?
|
| Signal Transduction | 9 | 2025 | 4725 | 0.310 |
Why?
|
| Pancreatic Stellate Cells | 2 | 2020 | 9 | 0.290 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 2683 | 0.280 |
Why?
|
| Cancer Pain | 2 | 2019 | 27 | 0.280 |
Why?
|
| Calcitonin Gene-Related Peptide | 2 | 2019 | 86 | 0.270 |
Why?
|
| Nigella | 1 | 2006 | 1 | 0.260 |
Why?
|
| Stilbenes | 2 | 2017 | 38 | 0.260 |
Why?
|
| Stress, Psychological | 3 | 2022 | 577 | 0.250 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2021 | 189 | 0.240 |
Why?
|
| Humans | 32 | 2025 | 132348 | 0.240 |
Why?
|
| Aptamers, Nucleotide | 1 | 2025 | 36 | 0.230 |
Why?
|
| src-Family Kinases | 1 | 2025 | 94 | 0.230 |
Why?
|
| Receptors, CXCR4 | 1 | 2025 | 71 | 0.230 |
Why?
|
| Cadherins | 1 | 2025 | 180 | 0.210 |
Why?
|
| Mice, Nude | 6 | 2025 | 757 | 0.200 |
Why?
|
| DNA Modification Methylases | 1 | 2023 | 51 | 0.200 |
Why?
|
| Methyltransferases | 1 | 2023 | 82 | 0.190 |
Why?
|
| Nerve Growth Factor | 2 | 2019 | 25 | 0.190 |
Why?
|
| Depression | 3 | 2022 | 1351 | 0.190 |
Why?
|
| Wakefulness | 1 | 2023 | 105 | 0.190 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2021 | 15 | 0.170 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2025 | 623 | 0.170 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2019 | 241 | 0.170 |
Why?
|
| Binding Sites | 2 | 2025 | 1255 | 0.170 |
Why?
|
| Animals | 18 | 2025 | 34995 | 0.170 |
Why?
|
| Disease Progression | 3 | 2023 | 2228 | 0.170 |
Why?
|
| Medicare | 1 | 2024 | 448 | 0.160 |
Why?
|
| Substance P | 2 | 2019 | 37 | 0.160 |
Why?
|
| Caveolin 1 | 1 | 2020 | 50 | 0.160 |
Why?
|
| Enzyme Inhibitors | 1 | 2023 | 589 | 0.160 |
Why?
|
| SMARCB1 Protein | 1 | 2020 | 48 | 0.160 |
Why?
|
| Astrocytes | 1 | 2023 | 270 | 0.160 |
Why?
|
| Survival Rate | 3 | 2024 | 2187 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2025 | 816 | 0.160 |
Why?
|
| DNA-Binding Proteins | 2 | 2021 | 1997 | 0.160 |
Why?
|
| Mice | 12 | 2025 | 18572 | 0.160 |
Why?
|
| Glutamic Acid | 1 | 2020 | 211 | 0.160 |
Why?
|
| Machine Learning | 1 | 2023 | 347 | 0.150 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2020 | 118 | 0.150 |
Why?
|
| Spinal Cord | 1 | 2021 | 274 | 0.150 |
Why?
|
| Colorectal Neoplasms | 1 | 2025 | 637 | 0.150 |
Why?
|
| Ischemic Postconditioning | 1 | 2018 | 5 | 0.150 |
Why?
|
| Antigens, CD34 | 1 | 2019 | 109 | 0.150 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2019 | 111 | 0.150 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2018 | 31 | 0.150 |
Why?
|
| Cognitive Dysfunction | 1 | 2023 | 313 | 0.150 |
Why?
|
| ErbB Receptors | 2 | 2023 | 295 | 0.150 |
Why?
|
| Deoxycytidine | 1 | 2018 | 83 | 0.140 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2018 | 21 | 0.140 |
Why?
|
| Glypicans | 1 | 2018 | 39 | 0.140 |
Why?
|
| Fluorouracil | 1 | 2018 | 139 | 0.140 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 238 | 0.140 |
Why?
|
| Neoplasm Metastasis | 3 | 2025 | 725 | 0.140 |
Why?
|
| Axons | 1 | 2021 | 394 | 0.140 |
Why?
|
| Menopause | 1 | 2018 | 90 | 0.140 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 482 | 0.140 |
Why?
|
| DNA | 1 | 2023 | 1484 | 0.140 |
Why?
|
| Tumor Cells, Cultured | 1 | 2019 | 1047 | 0.130 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2018 | 195 | 0.130 |
Why?
|
| beta Catenin | 1 | 2018 | 228 | 0.130 |
Why?
|
| Ornithine | 1 | 2016 | 32 | 0.130 |
Why?
|
| Vitis | 1 | 2016 | 14 | 0.130 |
Why?
|
| Nitrosamines | 1 | 2016 | 16 | 0.130 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 956 | 0.120 |
Why?
|
| Depressive Disorder, Major | 1 | 2022 | 461 | 0.120 |
Why?
|
| DNA Methylation | 1 | 2023 | 1132 | 0.120 |
Why?
|
| Securin | 1 | 2015 | 4 | 0.120 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2016 | 56 | 0.120 |
Why?
|
| Nerve Growth Factors | 1 | 2016 | 73 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2025 | 608 | 0.120 |
Why?
|
| TRPV Cation Channels | 1 | 2016 | 46 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2023 | 917 | 0.120 |
Why?
|
| Carcinogens | 1 | 2016 | 129 | 0.120 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 101 | 0.120 |
Why?
|
| Apoptosis | 5 | 2018 | 1904 | 0.120 |
Why?
|
| Antidepressive Agents | 1 | 2018 | 327 | 0.120 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 865 | 0.120 |
Why?
|
| Ischemia | 1 | 2018 | 373 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2020 | 1227 | 0.110 |
Why?
|
| Shock, Septic | 1 | 2016 | 156 | 0.110 |
Why?
|
| Transcription Factors | 1 | 2025 | 2494 | 0.110 |
Why?
|
| Exosomes | 1 | 2015 | 57 | 0.110 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2014 | 5 | 0.110 |
Why?
|
| Blotting, Western | 4 | 2018 | 1085 | 0.110 |
Why?
|
| Frontotemporal Dementia | 1 | 2015 | 73 | 0.110 |
Why?
|
| Glutamates | 1 | 2014 | 72 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2015 | 210 | 0.110 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2014 | 21 | 0.110 |
Why?
|
| Sp1 Transcription Factor | 1 | 2014 | 42 | 0.110 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2014 | 103 | 0.110 |
Why?
|
| Sumoylation | 1 | 2014 | 41 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 3 | 2025 | 1052 | 0.100 |
Why?
|
| Transcriptome | 1 | 2020 | 1125 | 0.100 |
Why?
|
| Lens, Crystalline | 1 | 2014 | 110 | 0.100 |
Why?
|
| Behavior, Animal | 3 | 2022 | 507 | 0.100 |
Why?
|
| Algorithms | 1 | 2020 | 1722 | 0.100 |
Why?
|
| Female | 11 | 2024 | 70795 | 0.100 |
Why?
|
| Cell Movement | 3 | 2025 | 891 | 0.090 |
Why?
|
| Prognosis | 2 | 2019 | 5010 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2014 | 454 | 0.090 |
Why?
|
| Genomics | 1 | 2020 | 1652 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 503 | 0.090 |
Why?
|
| Ovarian Neoplasms | 1 | 2015 | 463 | 0.090 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 1683 | 0.080 |
Why?
|
| Rats | 3 | 2022 | 3620 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2014 | 903 | 0.080 |
Why?
|
| Gene Regulatory Networks | 2 | 2023 | 383 | 0.080 |
Why?
|
| Brain | 1 | 2020 | 3198 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 1395 | 0.070 |
Why?
|
| Mutation | 4 | 2023 | 6248 | 0.070 |
Why?
|
| Male | 8 | 2024 | 65061 | 0.070 |
Why?
|
| Saponins | 1 | 2006 | 23 | 0.060 |
Why?
|
| Oleanolic Acid | 1 | 2006 | 8 | 0.060 |
Why?
|
| Growth Inhibitors | 1 | 2006 | 37 | 0.060 |
Why?
|
| Pancreas | 2 | 2018 | 222 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2014 | 1975 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 691 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2015 | 3062 | 0.060 |
Why?
|
| SELEX Aptamer Technique | 1 | 2025 | 6 | 0.060 |
Why?
|
| G-Quadruplexes | 1 | 2025 | 12 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 4695 | 0.060 |
Why?
|
| Aged | 6 | 2024 | 21381 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 2446 | 0.060 |
Why?
|
| RNA Interference | 2 | 2018 | 516 | 0.060 |
Why?
|
| Autophagy | 2 | 2021 | 428 | 0.060 |
Why?
|
| Molecular Docking Simulation | 1 | 2025 | 142 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 2453 | 0.050 |
Why?
|
| Anoikis | 1 | 2023 | 9 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 4767 | 0.050 |
Why?
|
| Supratentorial Neoplasms | 1 | 2024 | 40 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 998 | 0.050 |
Why?
|
| Cisplatin | 1 | 2025 | 281 | 0.050 |
Why?
|
| Arousal | 1 | 2023 | 81 | 0.050 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2024 | 133 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2024 | 212 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2024 | 217 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2023 | 160 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 1292 | 0.050 |
Why?
|
| Metformin | 1 | 2024 | 165 | 0.050 |
Why?
|
| Calcium Signaling | 1 | 2023 | 254 | 0.040 |
Why?
|
| Protein Binding | 1 | 2025 | 1735 | 0.040 |
Why?
|
| Proteomics | 1 | 2025 | 594 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 1723 | 0.040 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2022 | 165 | 0.040 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2020 | 30 | 0.040 |
Why?
|
| Electromyography | 1 | 2021 | 140 | 0.040 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2020 | 32 | 0.040 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2019 | 17 | 0.040 |
Why?
|
| Sleep | 1 | 2023 | 370 | 0.040 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2020 | 101 | 0.040 |
Why?
|
| Middle Aged | 5 | 2018 | 28891 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 7111 | 0.040 |
Why?
|
| Heterografts | 1 | 2020 | 199 | 0.040 |
Why?
|
| Glutamine | 1 | 2020 | 217 | 0.040 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 175 | 0.040 |
Why?
|
| Pentacyclic Triterpenes | 1 | 2018 | 7 | 0.040 |
Why?
|
| Adenylate Kinase | 1 | 2018 | 13 | 0.040 |
Why?
|
| Malondialdehyde | 1 | 2018 | 52 | 0.040 |
Why?
|
| Phenotype | 2 | 2021 | 4545 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2018 | 124 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 499 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2020 | 257 | 0.040 |
Why?
|
| Peroxidase | 1 | 2018 | 64 | 0.040 |
Why?
|
| Carthamus tinctorius | 1 | 2018 | 1 | 0.040 |
Why?
|
| Salvia miltiorrhiza | 1 | 2018 | 2 | 0.040 |
Why?
|
| Biogenic Monoamines | 1 | 2018 | 4 | 0.040 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2018 | 62 | 0.040 |
Why?
|
| Alanine Transaminase | 1 | 2018 | 160 | 0.040 |
Why?
|
| Metabolomics | 1 | 2022 | 478 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2018 | 176 | 0.030 |
Why?
|
| Reperfusion Injury | 1 | 2018 | 111 | 0.030 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2018 | 91 | 0.030 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2006 | 990 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2019 | 314 | 0.030 |
Why?
|
| Adult | 4 | 2020 | 31619 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 204 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 309 | 0.030 |
Why?
|
| Cecum | 1 | 2016 | 28 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2018 | 343 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 578 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 830 | 0.030 |
Why?
|
| Parkinson Disease | 1 | 2024 | 739 | 0.030 |
Why?
|
| Thymus Gland | 1 | 2016 | 100 | 0.030 |
Why?
|
| Hippocampus | 1 | 2022 | 819 | 0.030 |
Why?
|
| Capsaicin | 1 | 2016 | 20 | 0.030 |
Why?
|
| Pedigree | 1 | 2020 | 1725 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 869 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 544 | 0.030 |
Why?
|
| Atrophy | 1 | 2016 | 253 | 0.030 |
Why?
|
| Ganglia, Spinal | 1 | 2016 | 70 | 0.030 |
Why?
|
| Protein Interaction Maps | 1 | 2016 | 89 | 0.030 |
Why?
|
| Prions | 1 | 2015 | 16 | 0.030 |
Why?
|
| Nanotubes | 1 | 2015 | 18 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2016 | 239 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2016 | 99 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2016 | 295 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2015 | 341 | 0.030 |
Why?
|
| Texas | 1 | 2024 | 3629 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2015 | 124 | 0.030 |
Why?
|
| Glycolysis | 1 | 2015 | 167 | 0.030 |
Why?
|
| Lipids | 1 | 2018 | 563 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2020 | 748 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 306 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 399 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2016 | 332 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2018 | 1615 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2015 | 308 | 0.030 |
Why?
|
| K562 Cells | 1 | 2014 | 97 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 9945 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2016 | 430 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 5150 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2014 | 54 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 329 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2016 | 414 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2014 | 249 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2014 | 169 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 197 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2014 | 236 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 1759 | 0.030 |
Why?
|
| Drug Design | 1 | 2014 | 161 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2016 | 879 | 0.030 |
Why?
|
| Computational Biology | 1 | 2018 | 875 | 0.020 |
Why?
|
| DNA Primers | 1 | 2014 | 637 | 0.020 |
Why?
|
| Fibroblast Growth Factors | 1 | 2014 | 164 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2016 | 1570 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 515 | 0.020 |
Why?
|
| Leukemia | 1 | 2014 | 373 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 3853 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 2851 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1672 | 0.020 |
Why?
|
| Smoking | 1 | 2016 | 942 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 1368 | 0.020 |
Why?
|
| Mitochondria | 1 | 2015 | 752 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 686 | 0.020 |
Why?
|
| Liver | 1 | 2016 | 1816 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 3358 | 0.020 |
Why?
|
| Inflammation | 1 | 2016 | 1526 | 0.020 |
Why?
|
| United States | 1 | 2024 | 11628 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2024 | 17364 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2017 | 8568 | 0.010 |
Why?
|
| Time Factors | 1 | 2014 | 6456 | 0.010 |
Why?
|
| Infant | 1 | 2017 | 13195 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 13017 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2017 | 14857 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 20553 | 0.010 |
Why?
|
| Child | 1 | 2017 | 25827 | 0.010 |
Why?
|